These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3032227)

  • 1. Peripheral neutrophil inclusions in amiodarone treated patients.
    Adams PC; Sloan P; Morley AR; Holt DW
    Br J Clin Pharmacol; 1986 Dec; 22(6):736-8. PubMed ID: 3032227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-associated changes in human neutrophils.
    Somani P; Simon VA; Temesy-Armos PN; Gross SA; Didio LJ
    Am J Cardiol; 1986 Mar; 57(8):666-72. PubMed ID: 3953455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
    Somani P; Bandyopadhyay S; Klaunig JE; Gross SA
    Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
    Adams PC; Holt DW; Storey GC; Morley AR; Callaghan J; Campbell RW
    Circulation; 1985 Nov; 72(5):1064-75. PubMed ID: 3930086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.
    Hostetler KY; Vande Berg J; Aldern KA; Brophy GT
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):1007-13. PubMed ID: 1848974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular changes of rat myocardium after treatment with amiodarone or desethylamiodarone, studied with electron microscopy.
    Snyder VL; Bandyopadhyay S; Collins J; Gross SA; Somani P; Didio LJ
    J Submicrosc Cytol Pathol; 1990 Jan; 22(1):71-8. PubMed ID: 2155704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and red blood cell concentrations of amiodarone during chronic therapy.
    Heger JJ; Solow EB; Prystowsky EN; Zipes DP
    Am J Cardiol; 1984 Mar; 53(7):912-7. PubMed ID: 6538381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone and desethylamiodarone toxicity in isolated hepatocytes in culture.
    Gross SA; Bandyopadhyay S; Klaunig JE; Somani P
    Proc Soc Exp Biol Med; 1989 Feb; 190(2):163-9. PubMed ID: 2536944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
    Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
    Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro.
    Ogle CL; Reasor MJ
    Toxicology; 1990 May; 62(2):227-38. PubMed ID: 2162090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of lamellar body quantification in leukocytes in amiodarone toxicity].
    Vargas FS; Falzoni R; Terra Filho M; Cukier A; Carvalho-Pinto RM; Pileggi F
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):184-9. PubMed ID: 1668861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual variability of amiodarone distribution in plasma and erythrocytes: implications for therapeutic monitoring.
    Maling TJ; Siebers RW; Burgess CD; Taylor C; Purdie G
    Ther Drug Monit; 1989; 11(2):121-6. PubMed ID: 2718218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations.
    Storey GC; Holt DW; Holt P; Curry PV
    Ther Drug Monit; 1982; 4(4):385-8. PubMed ID: 7157462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-induced phospholipidosis in rat alveolar macrophages.
    Reasor MJ; Ogle CL; Walker ER; Kacew S
    Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy during longterm high-dose amiodarone therapy.
    Fraser AG; McQueen IN; Watt AH; Stephens MR
    J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):576-8. PubMed ID: 2989436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
    Nitsch J; Lüderitz B
    Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies.
    Somani P
    J Clin Pharmacol; 1989 May; 29(5):405-12. PubMed ID: 2544634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels.
    Kannan R; Yabek SM; Garson A; Miller S; McVey P; Singh BN
    Am Heart J; 1987 Aug; 114(2):283-7. PubMed ID: 3604884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.